Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis. Llufriu S, Sepúlveda M, Blanco Y, Marín P, Moreno B, Berenguer J, Gabilondo I, Martínez-Heras E, Sola-Valls N, Arnaiz J-A, et al. PLoS One. 2014; 9(12):e113936. Epub 2014 Dec 01. PMID: 25436769. Abstract CommentRecommendBookmarkWatch